Worries About Future Healthcare Costs Could Restrict Healthcare Spending Today By Asia Consumers
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The high cost of medical treatment is one of the biggest worries for people in Asia and one of the main drivers of the high savings rate across the region, but a recent survey across seven countries in Asia suggests a large number of consumers plan to increase spending on health insurance
You may also be interested in...
Victoza Approved In China: Novo Nordisk Gears Up To Conquer China's Diabetes Market
SHANGHAI - Denmark's Novo Nordisk AS announced March 15 that its human glucagon-like peptide-1 (GLP-1) analogue Victoza (liraglutide) was granted regulatory approval from China's State FDA, and plans to launch the anti-diabetes drug in the second half of this year
Taiwan's Health Minister Resigns Again After Failing To Reform National Health Insurance Scheme
HONG KONG - For the second time in less than a year, Taiwan's health minister offered his resignation after failing to get legislative approval for crucial reforms of the National Health Insurance system
China Signals Need For Private Investment To Support Its Healthcare Reforms; Private Insurance Options Likely To Widen
SHANGHAI - China recently lifted a ban on foreign investment in medical institutes to support its $124 billion healthcare reforms and the establishment of wholly foreign-owned hospitals and clinics. The move by the Chinese government is being read as a signal that China may open more of the country's healthcare industry to foreign investment